Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities

C-terminal binding proteins (CtBP1/2) are oncogenic transcriptional coregulators and dehydrogenases often overexpressed in multiple solid tumors, including breast, colon, and ovarian cancer, and associated with poor survival. CtBPs act by repressing expression of genes responsible for apoptosis (e.g...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Pharmacol
Glavni autori: Dcona, M. Michael, Damle, Priyadarshan K., Zarate-Perez, Francisco, Morris, Benjamin L., Nawaz, Zaid, Dennis, Michael J., Deng, Xiaoyan, Korwar, Sudha, Singh, Sahib J., Ellis, Keith C., Royer, William E., Bandyopadhyay, Dipankar, Escalante, Carlos, Grossman, Steven R.
Format: Artigo
Jezik:Inglês
Izdano: The American Society for Pharmacology and Experimental Therapeutics 2019
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6560337/
https://ncbi.nlm.nih.gov/pubmed/31036695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.118.114363
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items